20 (AIDX) Income towards Parent Company (2025 - 2026)
20 (AIDX) posted Income towards Parent Company of -$2.1 million for Q1 2026, down 174.43% on a QoQ basis from -$764462.0 in Q1 2025, and down 174.43% year-over-year from $2.8 million in Q1 2025.
20 (AIDX) Income towards Parent Company (2025 - 2026) Analysis & Trends
20's Income towards Parent Company history runs 2 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- Quarterly Income towards Parent Company fell 174.43% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (changed N/A YoY) and the FY2025 annual result came in at -$3.8 million, up 30.86% from the prior year.
- Income towards Parent Company was -$2.1 million for Q1 2026 at 20, down from -$764462.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$764462.0 in Q1 2025 and bottomed at -$2.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn |
| 10 | 20 | 3.48 Mn | -734,294.08 | 62,884.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10 Mn |
| Mar 31, 2025 | -764,462.00 |